He spends $2 million per year, takes 100+ supplements, dropped rapamycin in 2026, abandoned plasma transfusions from his son, and co-founded the Rejuvenation Olympics. His DunedinPACE score is 0.69 — among the lowest ever recorded. But is Bryan Johnson actually reversing his biological age, or is he proving that exercise, diet, and sleep do most of the heavy lifting?
Bryan Johnson — the tech entrepreneur who sold Braintree/Venmo to PayPal for $800 million in 2013 — launched Project Blueprint in 2021 as an all-encompassing effort to slow and reverse his biological aging. His protocol, as of early 2026, includes a strict plant-based diet consumed within a narrow eating window (~1,977 calories before 11 AM), over 100 daily supplements, rigorous exercise, optimized sleep, and regular experimental medical procedures.
His headline claims include: a DunedinPACE score of approximately 0.69 (meaning he ages 0.69 biological years per chronological year), organ-system ages equivalent to someone decades younger, #1 ranking on the Rejuvenation Olympics leaderboard, and what he has described as a 31-year reduction in his pace of aging. He publishes his biomarker data publicly and has become the most visible figure in the longevity movement, amplified by a 2025 Netflix documentary.
The central question is not whether Johnson is healthy. He clearly is. The question is: how much of his health is attributable to the $2 million/year protocol versus the foundational lifestyle habits anyone could implement for free?
Blueprint is not a single intervention — it's dozens of interventions layered on top of each other. To understand what's actually working, we need to grade each component individually.
| Intervention | Evidence | Grade |
|---|---|---|
| Exercise (Zone 2 + strength + HIIT) | Strong RCTs, massive mortality reduction | A |
| Sleep optimization (8:30 PM bedtime) | Strong observational + mechanistic data | A |
| Plant-rich whole food diet | PREDIMED, Blue Zones, large cohort studies | A |
| Caloric restriction (~1,977 cal) | CALERIE trial + animal data | B+ |
| Time-restricted eating | Promising human data, some conflicting results | B |
| Core supplements (D, omega-3, creatine, Mg) | Good evidence for deficiency correction | B |
| 100+ supplement stack (full protocol) | No trial has tested this combination | C |
| Rapamycin (dropped 2026) | Strong animal data, unknown human long-term safety | C+ |
| Young plasma transfusions (abandoned) | No human benefit; FDA warning | F |
| Gene therapy (abroad) | No published human longevity data | D |
The pattern is clear: the interventions with the strongest evidence are the ones that cost the least. Exercise, sleep, nutrition, and moderate caloric restriction have decades of human data behind them. The expensive, experimental interventions — the ones that generate headlines — have the weakest evidence and, in several cases, have been abandoned by Johnson himself.
Johnson's health outcomes are real. His interpretation of what's causing them exceeds what the evidence supports. The core lifestyle practices are Grade A science. The $2M/year experimental layer is uncontrolled, n=1, and has produced several public failures. His most valuable contribution may be demonstrating — unintentionally — that the basics work extraordinarily well.
Johnson's most publicized claim is that he has reversed his pace of aging by the equivalent of 31 years. He bases this on his DunedinPACE score of approximately 0.66: multiplying 0.66 by his chronological age of 47 yields ~31 years. This math implies he has the biological age of a 31-year-old.
Dr. Morgan Levine, the scientist whose work underpins advanced epigenetic clocks, has publicly disputed this calculation. Levine explained that DunedinPACE measures a rate — how fast you are aging right now — not an accumulation over a lifetime. Applying a current rate to an entire lifespan assumes you've been aging at that rate since birth, which is biologically incoherent. A more defensible interpretation: Johnson is currently aging at 66% of the average rate. That's impressive. It is not the same as being biologically 31.
Additionally, epigenetic clocks were designed to estimate aging in populations, not to track individual interventions over short time periods. A person's epigenetic age can fluctuate based on recent illness, stress, exercise timing, and even the time of day a blood sample is drawn. Single data points are noisy. Trends across multiple tests over years are more meaningful.
Worth noting: Johnson himself has acknowledged that diet, exercise, and good sleep are "probably the main reasons" for his improved longevity biomarkers. This admission — buried beneath the headlines — is perhaps the most important data point in the entire Blueprint experiment.
One of the most revealing aspects of Blueprint is what Johnson has stopped doing. Unlike most longevity influencers, Johnson publishes his data and drops interventions when the numbers don't support them. This intellectual honesty is commendable — but the pattern of abandonment reveals how speculative much of the protocol has been.
In 2023, Johnson received blood plasma from his 17-year-old son Talmage, inspired by parabiosis research in mice. He later acknowledged the results were inconclusive and discontinued the practice. The FDA had previously stated that such transfusions have no proven clinical benefit in humans and may carry risks. A 2023 randomized trial published in Nature Aging found minimal benefits from young plasma infusions in older adults.
Rapamycin — the mTOR inhibitor that extends lifespan 10–25% in mice — was one of the most discussed components of Blueprint. In 2026, Johnson removed it from his protocol due to side effects. Known risks include impaired wound healing, elevated lipids, immunosuppression, and glucose disruption. As we noted in our rapamycin evidence review, the human safety profile for healthy longevity use remains unestablished. If the person spending more on health optimization than anyone else on Earth decides the risk-benefit doesn't work, that's a meaningful signal.
Johnson has undergone various stem cell procedures for tissue rejuvenation. Published evidence for these specific applications in healthy humans is minimal. The longevity claims around autologous stem cell therapies remain largely theoretical.
The interventions that survived years of Johnson's self-experimentation are the ones with the strongest pre-existing evidence: structured exercise, a plant-rich diet, caloric moderation, optimized sleep, and a handful of well-studied supplements (vitamin D, omega-3s, creatine, magnesium). The experimental frontier has been progressively pruned.
Dr. Morgan Levine (pioneer of advanced epigenetic clocks): Has publicly stated that DunedinPACE cannot be used to make the claims Johnson has made about age reversal. While Johnson's reduced epigenetic age suggests improved health trajectory, the calculation methodology behind his headline claims is not supported by the science of the clocks themselves.
Dr. Vadim Gladyshev (Harvard aging researcher, featured in the Netflix documentary): Has stated that Johnson's usage of rapamycin was not a proper experiment and that his self-experiments have "almost no contribution to science" because they lack controls, randomization, and proper methodology.
Dr. Nir Barzilai (centenarian researcher, TAME trial PI): Has consistently emphasized that centenarians share relatively simple characteristics — they are not obese, they stay physically active, they maintain social connections. His research suggests that the variance in human lifespan is explained far more by these fundamentals than by any supplement regimen.
Dr. Moshe Szyf (McGill University pharmacologist): Has expressed skepticism that science is currently capable of achieving the results Johnson claims. The gap between Johnson's marketing and the validated science remains wide.
Dr. Matt Kaeberlein (former director of Optispan Academy, Dog Aging Project): Has been careful to distinguish between evidence-based lifestyle interventions and the speculative frontier. Without a control version of Johnson who only did the basics, there is no way to isolate the expensive interventions' contribution.
It would be unfair to dismiss Blueprint entirely. Johnson deserves credit for several things that are genuinely advancing the conversation around longevity.
Radical transparency. Publishing biomarker data publicly — including failures — sets a higher standard than the supplement industry's typical opacity. When Johnson drops an intervention because it didn't work, the longevity community learns from it.
Making biological age testing mainstream. The Rejuvenation Olympics, whatever its scientific limitations, has made millions of people aware that biological age is measurable, modifiable, and worth tracking. This is a net positive for public health literacy.
Demonstrating the power of the basics. Ironically, Blueprint's most important finding may be the one Johnson doesn't emphasize: that disciplined execution of exercise, nutrition, and sleep optimization produces extraordinary biomarker improvements. His DunedinPACE is impressive — but it's likely impressive primarily because he exercises intensely, eats a whole-food diet in a restricted window, and sleeps with military discipline.
Iterative, data-driven protocol design. The willingness to drop rapamycin, abandon plasma transfusions, and reduce NMN dosing based on personal data is a model of intellectual honesty, even if the experimental design (n=1, no controls) limits scientific conclusions.
Blueprint's most important lesson is the cost curve of longevity interventions. The relationship between spending and health benefit is not linear — it's logarithmic. The first $100/month buys the vast majority of the benefit. Each additional dollar buys progressively less.
Under $100/month (captures ~80–90% of Blueprint's benefit): structured exercise (free), sleep optimization (free), time-restricted eating (free), whole-food plant-rich diet (grocery costs), vitamin D, omega-3s, creatine, and magnesium.
$100–$500/month (marginal additional benefit): annual epigenetic testing, expanded supplement stack, blood panel optimization, VO2 max testing.
$2M/year (Blueprint tier): full medical team, experimental procedures, 100+ supplements, gene therapy abroad, continuous monitoring of every measurable parameter. Evidence of incremental benefit over the $500/month tier: unproven.
This isn't speculation. Johnson himself has stated that diet, exercise, and sleep probably explain most of his results. Multiple independent analyses — including from his own former chief scientist, Dr. Oliver Zolman, who departed the Rejuvenation Olympics citing concerns about scientific integrity — support this conclusion.
Bryan Johnson is genuinely healthy. His biomarkers are excellent. His willingness to publish data — including his failures — contributes something real to the longevity conversation. The Rejuvenation Olympics and the Netflix documentary have brought biological age testing to mainstream awareness, which is valuable.
But the claims exceed the evidence. The "aging backwards by 31 years" framing has been disputed by the scientist whose work it's based on. The protocol is an n=1 experiment with no control group, which represents the lowest tier of scientific evidence. The most expensive and speculative interventions have been progressively abandoned. And the interventions that survived are the ones your doctor would recommend for free.
The most useful way to think about Bryan Johnson is not as a scientific authority but as an extremely well-funded case study in what happens when you relentlessly optimize the fundamentals. His results confirm what longevity science has been saying for decades: exercise intensely, eat well, sleep deeply, manage stress, and monitor your biomarkers. Everything else is noise — expensive, fascinating, headline-generating noise — but noise.
You don't need $2 million. You need consistency.